Comparative Efficacy of Bortezomib, Melphalan, and Prednisone (VMP) With or Without Daratumumab Versus VMP Alone in the Treatment of Newly Diagnosed Multiple Myeloma: Propensity Score Matching of ALCYONE and VISTA Phase III Studies.

Comparative Efficacy of Bortezomib, Melphalan, and Prednisone (VMP) With or Without Daratumumab Versus VMP Alone in the Treatment of Newly Diagnosed Multiple Myeloma: Propensity Score Matching of ALCYONE and VISTA Phase III Studies. Clin Lymphoma Myeloma Leuk. 2020 07; 20(7):480-489.

View in: PubMed

subject areas

Antibodies, Monoclonal
Antineoplastic Combined Chemotherapy Protocols
Bortezomib
Female
Humans
Male
Melphalan
Multiple Myeloma
Prednisone
Propensity Score
Treatment Outcome

authors with profiles

Andrzej Jakubowiak